Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
Cell
; 184(10): 2587-2594.e7, 2021 05 13.
Article
in English
| MEDLINE | ID: covidwho-1157175
ABSTRACT
The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing, we investigated the prevalence and dynamics of this variant in the United States (US), tracking it back to its early emergence. We found that, while the fraction of B.1.1.7 varied by state, the variant increased at a logistic rate with a roughly weekly doubling rate and an increased transmission of 40%-50%. We revealed several independent introductions of B.1.1.7 into the US as early as late November 2020, with community transmission spreading it to most states within months. We show that the US is on a similar trajectory as other countries where B.1.1.7 became dominant, requiring immediate and decisive action to minimize COVID-19 morbidity and mortality.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
/
Models, Biological
Type of study:
Observational study
/
Prognostic study
Topics:
Variants
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
North America
Language:
English
Journal:
Cell
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS